Jafri, M., Whitworth, J., Rattenberry, E., Vialard, L., Kilby, G., Kumar, A. V., Izatt, L., Lalloo, F., Brennan, P., Cook, J., Morrison, P. J., Canham, N., Armstrong, R., Brewer, C., Tomkins, S., Donaldson, A., Barwell, J., Cole, T. R., Atkinson, A. B., Aylwin, S., Ball, S. G., Srirangalingam, U., Chew, S. L., Evans, D. G. R., Hodgson, S. V., Irving, R., Woodward, E., Macdonald, F., & Maher, E. R. (n.d.). evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non‐syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma. Clinical endocrinology, 78, 898–906. http://access.bl.uk/ark:/81055/vdc_100024494005.0x000029